Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for prevention of preterm pre-eclampsia in overweight Chinese pregnancies
ChiCTR2100051255Phase 4Recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Sep 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metformin and aspirin in preeclampsia (3 arms), sponsored by Peking University Third Hospital. Primary endpoint: Incidence of pre-eclampsia in Chinese overweight pregnancies. Started Sep 2021; status: recruiting.
02
Drugs
metforminaspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on ChiCTR2100051255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051255.